# Iridium Communications Inc.: financial statements, quarterly

IRDM · Nasdaq · CIK 1418819 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/irdm.md) · [Financials](/companies/irdm/financials.md) · [Filings](/companies/irdm/filings.md) · [Insiders](/companies/irdm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/irdm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [195 d](/filings/0001418819-26-000009.md) | [204](/filings/0001628280-25-018712.md) | [201](/filings/0001628280-25-035835.md) | [213](/filings/0001418819-25-000009.md) | [213 d](/filings/0001418819-26-000009.md) | [215](/filings/0001418819-26-000026.md) | [217](/filings/0001418819-26-000045.md) | [227](/filings/0001418819-26-000052.md) | [213 d](/filings/0001418819-26-000009.md) | [219](/filings/0001418819-26-000026.md) | [225](/filings/0001418819-26-000045.md) | [246](/filings/0001418819-26-000052.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [5.7 d](/filings/0001418819-26-000009.md) | [7.2](/filings/0001628280-25-018712.md) | [6.5](/filings/0001628280-25-035835.md) | [6.2](/filings/0001418819-25-000009.md) | [8.5 d](/filings/0001418819-26-000009.md) | [5.4](/filings/0001418819-26-000026.md) | [4.3](/filings/0001418819-26-000045.md) | [4.9](/filings/0001418819-26-000052.md) | [5.1 d](/filings/0001418819-26-000009.md) | [6.2](/filings/0001418819-26-000026.md) | [5.5](/filings/0001418819-26-000045.md) | [4.8](/filings/0001418819-26-000052.md) |
| Selling, general and administrative | $m | [34.3 d](/filings/0001418819-26-000009.md) | [36.8](/filings/0001628280-25-018712.md) | [46.7](/filings/0001628280-25-035835.md) | [44.0](/filings/0001418819-25-000009.md) | [40.7 d](/filings/0001418819-26-000009.md) | [35.8](/filings/0001418819-26-000026.md) | [44.6](/filings/0001418819-26-000045.md) | [35.5](/filings/0001418819-26-000052.md) | [41.8 d](/filings/0001418819-26-000009.md) | [45.8](/filings/0001418819-26-000026.md) | [67.0](/filings/0001418819-26-000045.md) | [74.9](/filings/0001418819-26-000052.md) |
| Operating income | $m | [46.3 d](/filings/0001418819-26-000009.md) | [49.8](/filings/0001628280-25-018712.md) | [43.6](/filings/0001628280-25-035835.md) | [54.9](/filings/0001418819-25-000009.md) | [52.1 d](/filings/0001418819-26-000009.md) | [60.4](/filings/0001418819-26-000026.md) | [50.3](/filings/0001418819-26-000045.md) | [70.1](/filings/0001418819-26-000052.md) | [55.2 d](/filings/0001418819-26-000009.md) | [50.7](/filings/0001418819-26-000026.md) | [34.0](/filings/0001418819-26-000045.md) | [31.6](/filings/0001418819-26-000052.md) |
| Interest expense | $m | [0.0 d](/filings/0001418819-24-000008.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(9.6) d](/filings/0001418819-26-000009.md) | [7.9](/filings/0001628280-25-018712.md) | [4.6](/filings/0001628280-25-035835.md) | [6.0](/filings/0001418819-25-000009.md) | [(6.2) d](/filings/0001418819-26-000009.md) | [5.8](/filings/0001418819-26-000026.md) | [3.8](/filings/0001418819-26-000045.md) | [10.0](/filings/0001418819-26-000052.md) | [8.0 d](/filings/0001418819-26-000009.md) | [8.8](/filings/0001418819-26-000026.md) | [3.1](/filings/0001418819-26-000045.md) | [2.2](/filings/0001418819-26-000052.md) |
| Net income | $m | [38.0 d](/filings/0001418819-26-000009.md) | [19.7](/filings/0001628280-25-018712.md) | [32.3](/filings/0001628280-25-035835.md) | [24.4](/filings/0001418819-25-000009.md) | [36.3 d](/filings/0001418819-26-000009.md) | [30.4](/filings/0001418819-26-000026.md) | [22.0](/filings/0001418819-26-000045.md) | [37.1](/filings/0001418819-26-000052.md) | [24.9 d](/filings/0001418819-26-000009.md) | [21.6](/filings/0001418819-26-000026.md) | [9.7](/filings/0001418819-26-000045.md) | [107](/filings/0001418819-26-000052.md) |
| Diluted EPS | $ per share | not reported | [0.16](/filings/0001628280-25-018712.md) | [0.27](/filings/0001628280-25-035835.md) | [0.21](/filings/0001418819-25-000009.md) | not reported | [0.27](/filings/0001418819-26-000026.md) | [0.20](/filings/0001418819-26-000045.md) | [0.35](/filings/0001418819-26-000052.md) | not reported | [0.20](/filings/0001418819-26-000026.md) | [0.09](/filings/0001418819-26-000045.md) | [0.98](/filings/0001418819-26-000052.md) |
| Basic EPS | $ per share | not reported | [0.16](/filings/0001628280-25-018712.md) | [0.27](/filings/0001628280-25-035835.md) | [0.21](/filings/0001418819-25-000009.md) | not reported | [0.28](/filings/0001418819-26-000026.md) | [0.20](/filings/0001418819-26-000045.md) | [0.35](/filings/0001418819-26-000052.md) | not reported | [0.20](/filings/0001418819-26-000026.md) | [0.09](/filings/0001418819-26-000045.md) | [1.00](/filings/0001418819-26-000052.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [71.9](/filings/0001628280-25-005302.md) | [174](/filings/0001418819-24-000023.md) | [63.5](/filings/0001418819-24-000037.md) | [160](/filings/0001628280-24-042983.md) | [93.5](/filings/0001418819-26-000009.md) | [50.9](/filings/0001628280-25-018712.md) | [79.3](/filings/0001628280-25-035835.md) | [88.5](/filings/0001418819-25-000009.md) | [96.5](/filings/0001418819-26-000052.md) | [112](/filings/0001418819-26-000026.md) | [184](/filings/0001418819-26-000045.md) | [97.9](/filings/0001418819-26-000052.md) |
| Current assets | $m | [271](/filings/0001628280-25-005302.md) | [377](/filings/0001418819-24-000023.md) | [264](/filings/0001418819-24-000037.md) | [355](/filings/0001628280-24-042983.md) | [293](/filings/0001418819-26-000009.md) | [257](/filings/0001628280-25-018712.md) | [255](/filings/0001628280-25-035835.md) | [276](/filings/0001418819-25-000009.md) | [277](/filings/0001418819-26-000052.md) | [309](/filings/0001418819-26-000026.md) | [377](/filings/0001418819-26-000045.md) | [307](/filings/0001418819-26-000052.md) |
| Total assets | $m | [2,662](/filings/0001628280-25-005302.md) | [2,736](/filings/0001418819-24-000023.md) | [2,718](/filings/0001418819-24-000037.md) | [2,751](/filings/0001628280-24-042983.md) | [2,671](/filings/0001418819-26-000009.md) | [2,610](/filings/0001628280-25-018712.md) | [2,568](/filings/0001628280-25-035835.md) | [2,554](/filings/0001418819-25-000009.md) | [2,531](/filings/0001418819-26-000052.md) | [2,532](/filings/0001418819-26-000026.md) | [2,565](/filings/0001418819-26-000045.md) | [3,082](/filings/0001418819-26-000052.md) |
| Current liabilities | $m | [132](/filings/0001628280-25-005302.md) | [113](/filings/0001418819-24-000023.md) | [118](/filings/0001418819-24-000037.md) | [135](/filings/0001628280-24-042983.md) | [169](/filings/0001418819-26-000009.md) | [129](/filings/0001628280-25-018712.md) | [102](/filings/0001628280-25-035835.md) | [103](/filings/0001418819-25-000009.md) | [112](/filings/0001418819-26-000052.md) | [108](/filings/0001418819-26-000026.md) | [136](/filings/0001418819-26-000045.md) | [337](/filings/0001418819-26-000052.md) |
| Total liabilities | $m | [1,774](/filings/0001628280-25-005302.md) | [1,882](/filings/0001418819-24-000023.md) | [1,931](/filings/0001418819-24-000037.md) | [2,087](/filings/0001628280-24-042983.md) | [2,095](/filings/0001418819-26-000009.md) | [2,092](/filings/0001628280-25-018712.md) | [2,094](/filings/0001628280-25-035835.md) | [2,104](/filings/0001418819-25-000009.md) | [2,068](/filings/0001418819-26-000052.md) | [2,064](/filings/0001418819-26-000026.md) | [2,093](/filings/0001418819-26-000045.md) | [2,505](/filings/0001418819-26-000052.md) |
| Long-term debt | $m | [1,467](/filings/0001628280-25-005302.md) | not reported | not reported | not reported | [1,758](/filings/0001418819-26-000009.md) | not reported | not reported | not reported | [1,757](/filings/0001418819-26-000009.md) | not reported | not reported | not reported |
| Current portion of debt | $m | [15.0](/filings/0001418819-24-000008.md) | not reported | not reported | not reported | [33.1](/filings/0001628280-25-005302.md) | not reported | not reported | not reported | [3.4](/filings/0001418819-26-000009.md) | not reported | not reported | not reported |
| Short-term borrowings | $m | [15.0](/filings/0001628280-25-005302.md) | not reported | not reported | not reported | [33.1](/filings/0001418819-26-000009.md) | not reported | not reported | not reported | [3.4](/filings/0001418819-26-000009.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [888](/filings/0001418819-26-000009.md) | [854](/filings/0001628280-25-035835.md) | [787](/filings/0001418819-25-000009.md) | [664](/filings/0001418819-25-000009.md) | [577](/filings/0001418819-26-000052.md) | [518](/filings/0001418819-26-000045.md) | [474](/filings/0001418819-26-000052.md) | [450](/filings/0001418819-26-000052.md) | [463](/filings/0001418819-26-000052.md) | [468](/filings/0001418819-26-000045.md) | [473](/filings/0001418819-26-000052.md) | [577](/filings/0001418819-26-000052.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [87.8 d](/filings/0001418819-26-000009.md) | [71.4](/filings/0001628280-25-018712.md) | [81.1 d](/filings/0001628280-25-035835.md) | [119 d](/filings/0001418819-25-000009.md) | [105 d](/filings/0001418819-26-000009.md) | [61.1](/filings/0001418819-26-000026.md) | [130 d](/filings/0001418819-26-000045.md) | [101 d](/filings/0001418819-26-000052.md) | [109 d](/filings/0001418819-26-000009.md) | [71.6](/filings/0001418819-26-000026.md) | [114 d](/filings/0001418819-26-000045.md) | [95.9 d](/filings/0001418819-26-000052.md) |
| Capital expenditure | $m | [16.2 d](/filings/0001418819-26-000009.md) | [14.6](/filings/0001628280-25-018712.md) | [12.4 d](/filings/0001628280-25-035835.md) | [18.6 d](/filings/0001418819-25-000009.md) | [24.3 d](/filings/0001418819-26-000009.md) | [24.5](/filings/0001418819-26-000026.md) | [20.7 d](/filings/0001418819-26-000045.md) | [21.5 d](/filings/0001418819-26-000052.md) | [33.5 d](/filings/0001418819-26-000009.md) | [30.0](/filings/0001418819-26-000026.md) | [21.8 d](/filings/0001418819-26-000045.md) | [27.4 d](/filings/0001418819-26-000052.md) |
| Dividends paid | $m | [16.0 d](/filings/0001418819-26-000009.md) | [16.1](/filings/0001628280-25-018712.md) | [32.8](/filings/0001628280-25-035835.md) | [49.1](/filings/0001418819-25-000009.md) | [15.6 d](/filings/0001418819-26-000009.md) | [15.7](/filings/0001418819-26-000026.md) | [30.8](/filings/0001628280-25-035835.md) | [46.9](/filings/0001418819-25-000009.md) | [16.0 d](/filings/0001418819-26-000009.md) | [16.5](/filings/0001418819-26-000026.md) | [16.2 d](/filings/0001418819-26-000045.md) | [16.2 d](/filings/0001418819-26-000052.md) |
| Share repurchases | $m | [51.9 d](/filings/0001418819-26-000009.md) | [57.2](/filings/0001628280-25-018712.md) | [97.6 d](/filings/0001628280-25-035835.md) | [130 d](/filings/0001418819-25-000009.md) | [123 d](/filings/0001418819-26-000009.md) | [70.5](/filings/0001418819-26-000026.md) | [65.6 d](/filings/0001418819-26-000045.md) | [50.4 d](/filings/0001418819-26-000052.md) | [(0.0) d](/filings/0001418819-26-000009.md) | [0.0](/filings/0001418819-26-000026.md) | [0.0 d](/filings/0001418819-26-000045.md) | [0.0 d](/filings/0001418819-26-000052.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [129](/filings/0001418819-24-000023.md) | [126](/filings/0001418819-24-000037.md) | [125](/filings/0001628280-24-042983.md) | [124](/filings/0001628280-25-018712.md) | [121](/filings/0001628280-25-035835.md) | [118](/filings/0001418819-25-000009.md) | [111](/filings/0001418819-26-000026.md) | [108](/filings/0001418819-26-000045.md) | [106](/filings/0001418819-26-000052.md) | [107](/filings/0001418819-26-000026.md) | [108](/filings/0001418819-26-000045.md) | [109](/filings/0001418819-26-000052.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 106,158,479 at 2026-10-13, from the cover of the [10-Q filed 2026-10-20](/filings/0001418819-26-000052.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.